Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis.
[The role of vitamin D in multiple sclerosis].
Neurons and T cells: Understanding this interaction for inflammatory neurological diseases.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis.
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Management of faecal incontinence and constipation in adults with central neurological diseases.
DSM-III disorders from age 11 to age 15 years.
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
[Affective and psychotic disorders in multiple sclerosis].
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Facilitation of Corticospinal Connections in Able-bodied People and People With Central Nervous System Disorders Using Eight Interventions.
Missing links in multiple sclerosis etiology. A working connecting hypothesis.
Factors for lower walking speed in persons with multiple sclerosis.
Interleukin-6 control of early Theiler's Murine Encephalomyelitis Virus replication in macrophages occurs in conjunction with STAT1 activation and nitric oxide production.
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Intractable hiccup caused by spinal cord lesions in demyelination disease.
[New and emerging treatments for multiple sclerosis].
Pages
« first
‹ previous
…
324
325
326
327
328
329
330
331
332
…
next ›
last »